Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sigma Healthcare Ltd ( (AU:SIG) ) has shared an update.
Sigma Healthcare Ltd has issued a correction to an earlier filed Appendix 3X regarding the shareholding of its director, Jack Gance. An administrative oversight led to the omission of 2,205 ordinary shares directly held by Mr. Gance, which have now been corrected in the records. This adjustment increases his total shareholding to 1,579,052,263 shares. Sigma emphasizes its commitment to compliance with ASX disclosure requirements and assures stakeholders that this was an isolated incident, with no impact on recent voting outcomes at the company’s extraordinary general meeting.
The most recent analyst rating on (AU:SIG) stock is a Buy with a A$3.45 price target. To see the full list of analyst forecasts on Sigma Healthcare Ltd stock, see the AU:SIG Stock Forecast page.
More about Sigma Healthcare Ltd
Sigma Healthcare Ltd is a company operating in the healthcare industry, primarily focusing on the distribution of pharmaceutical products and services. It is known for its extensive network and market presence in Australia, providing essential healthcare solutions.
Average Trading Volume: 33,944,146
Technical Sentiment Signal: Buy
Current Market Cap: A$32.84B
Learn more about SIG stock on TipRanks’ Stock Analysis page.